NLRP3 and inflammatory bowel disease: Other bacteria, such as enterotoxigenic B. fragilis, regulate the NLRP3 inflammasome through ROS and butyrate, promoting pyroptosis and potentially contributing to IBD, while nontoxigenic B. fragilis exhibits anti‐inflammatory effects by inhibiting NLRP3‐mediated inflammatory signaling pathways to reduce intestinal inflammation.63